Abstract: Activity-dependent postsynaptic receptor trafficking is critical for long-term synaptic plasticity in the brain, but it is unclear whether this mechanism actually mediates the spinal cord dorsal horn central sensitization (a specific form of synaptic plasticity) that is associated with persistent pain. Recent studies have shown that peripheral inflammation drives changes in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit trafficking in the dorsal horn and that such changes contribute to the hypersensitivity that underlies persistent pain. Here, we review current evidence to illustrate how spinal cord AMPARs participate in the dorsal horn central sensitization associated with persistent pain. Understanding these mechanisms may allow the development of novel therapeutic strategies for treating persistent pain.
Introduction
Persistent or chronic pain arising from inflammation and tissue or nerve injury is one of the most common syndromes seen clinically. Despite intensive research into the neurobiologic mechanisms of persistent pain during the past decades, it is still poorly managed by current drugs such as opioids and nonsteroidal anti-inflammatory drugs [1] . Persistent pain is characterized by spontaneous or intermittent burning pain, an exaggerated response to painful stimuli (hyperalgesia), and pain in response to normally innocuous stimuli (allodynia). It is believed that a specific form of synaptic plasticity known as central sensitization underlies the mechanisms by which persistent pain develops and is maintained. Understanding such mechanisms will allow the development of novel therapeutic strategies to treat persistent pain.
The α-amino-3-hydroxy-5-methyl-4-isoxazolepro pionic acid (AMPA) receptor (AMPAR) is a glutamate ionotropic receptor that is integral to fast excitatory synaptic transmission and plasticity at synapses in the central nervous system [2, 3] . In addition to mediating the acute spinal processing of nociceptive and non-nociceptive inputs, AMPARs in the dorsal horn may also participate in central sensitization under persistent pain conditions [4] . Multiple intrathecal treatment with the non-selective AMPAR antagonist CNQX beginning 15 min prior to nerve ligation significantly (but not completely) reduces the development of nerve injuryinduced thermal hyperalgesia, and this effect persists for up to 10 days [5] . Interestingly, single intrathecal post-treatment with selective or nonselective AMPAR antagonists partially and temporarily attenuates thermal hyperalgesia and mechanical allodynia after peripheral nerve injury [5, 6] .
Inhibition of spinal Ca
2+
-permeable AMPAR blocks thermal injury-induced mechanical allodynia and carrageenaninduced thermal hyperalgesia and mechanical allodynia [7, 8] .
Furthermore, intrathecal administration of selective AM-PAR antagonists attenuates complete Freund's adjuvant (CFA)-induced mechanical and thermal pain hypersensitivity during both the development and maintenance of persistent pain at doses that do not affect locomotor function or responsiveness to acute pain [9] . Electrophysiologic studies revealed that AMPAR blockade reduces the receptive field areas of superficial dorsal horn neurons [10, 11] .
Using mice that lack GluA1, GluA2, or GluA3, Hartmann et al. [12] demonstrated that AMPARs are critical determi- and that these changes contribute to central sensitization in the development and maintenance of persistent inflammatory pain [4] . Here I review the current evidence regarding changes in AMPAR subunit trafficking in dorsal horn neurons after peripheral inflammation and tissue or nerve injury and discuss potential mechanisms by which such changes participate in the development and maintenance of persistent pain.
AMPAR channel structure and expression in spinal cord
AMPARs are composed of four subunits, GluA1 to GluA4 (or GluR1 to GluR4). Each subunit comprises an N-terminal extracellular amino domain, a ligand-binding domain, a receptor-channel domain, and an intracellular C-terminal domain [3] . It should be emphasized that the receptor-channel domain consists of three transmembrane segments (M1, M3, and M4) and one re-entrant loop within the membrane (M2). Because the M2 loop forms part of the channel pore, it controls the flow of ions (e.g. Ca 2+ )
through the AMPAR channel [13, 14] . In addition, the C-terminal intracellular domain presents multiple protein phosphorylation sites for various known protein kinases such as protein kinase A (PKA), protein kinase C (PKC), and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), and several binding motifs for various membrane-related and intracellular proteins, e.g. the scaffolding proteins [13, 14] . Functional
AMPARs are homomeric or heteromeric tetramers of GluR subunits. In the adult mammalian central nervous system, GluA1 and GluA2 subunits are ubiquitously expressed and present in most AMPARs. Whereas GluA1, GluA3, and
GluA4 convey high Ca 2+ permeability to AMPAR channels, GluA2 imparts low Ca 2+ permeability because it carries an arginine residue in its pore-forming M2 segment (inserted by Q/R site RNA editing during development) [3] .
Morphological studies indicate that all four GluR subunits are found within the dorsal horn of the spinal cord [15] [16] [17] . GluA1 is highly expressed in the superficial dorsal horn (laminae I-II) but exhibits low expression in the deeper dorsal horn [4] . GluA2 expression has been observed throughout the dorsal horn, but it is distributed predominately in inner lamina II [4] . GluA3 is weakly expressed in the deep laminae. GluA4 was recently detected in large NK1 receptor-expressing projection neurons in lamina I [18] .
Under electron microscopy, most GluA1 and GluA2 immunoreactive products are restricted to the postsynaptic density, with little reactivity in axons and terminals in the superficial dorsal horn [4] . Thus, GluA1 and GluA2 are the two key subunits that comprise the AMPAR channel in the dorsal horn. protein and correspondingly reduces the amount of cytosolic GluA1, without changing total GluA1 or GluA2 protein levels in the dorsal horn [19] ( Table 1) . Another study demonstrated that capsaicin injection into rat hind-paw increases the density of GluA1-containing AMPARs and the ratio of GluA1 to GluA2/3 in postsynaptic membrane in the superficial dorsal horn [20] . In addition, pain hypersensitivity evoked by intraplantar carrageenan and pain behaviors induced by intraplantar formalin are associated with the movement of GluA1, but not GluA2, into neuronal membrane in the dorsal horn [21, 22] (Table 1) . Interestingly, intraplantar injection of CFA into a hind-paw produces changes in the subcellular distribution of both GluA1 and GluA2 proteins in dorsal horn neurons, although it does not alter the total expression of GluA1 and GluA2 proteins [9, 23] ( Table 1 ). The level of cytosolic GluA2 is markedly increased, and the level of membrane-bound GluA2 is significantly decreased in the dorsal horn 1 and 3 days after CFA injection [9, 23] . Conversely, the amount of GluA1 is significantly reduced in cytosol and increased in the neuronal membrane 1 day after CFA injection [9] . Furthermore, researchers found decreased synaptic GluA2 and increased extrasynaptic GluA1 in the superficial dorsal horn 1 day after CFA injection [23] [24] [25] . In contrast, peripheral incision and nerve injury failed to alter the expression and localization of GluA1 or GluA2 in cytosolic and plasma membrane fractions from the dorsal horn [26, 27] . This evidence indicates that different peripheral nociceptive insults produce distinct changes in dorsal horn AMPAR subunit trafficking.
Peripheral noxious insults also alter the properties of synaptic and extrasynaptic AMPARs in dorsal horn neurons. One key property that is altered is Ca 2+ permeability.
Selectively blocking Ca 2+ -permeable AMPARs inhibits AMPAR-mediated evoked excitatory postsynaptic currents (eEPSCs) to a greater degree in lamina II neurons from CFA-treated animals than in those from saline-treated animals [23] , indicating that CFA injection increases synaptic Ca 2+ -permeable AMPARs in the superficial dorsal horn.
Compared to saline, CFA also enhances the inward rectification of eEPSCs and significantly reduces the rectification index in lamina I projection neurons [28] and lamina II interneurons [23, 24] 1 day after CFA injection. In addition, extrasynaptic AMPAR currents and Ca 2+ permeability increase dramatically in the lamina II neurons characterized by intrinsic tonic firing properties, but not in those that exhibit strong adaptation, 1 day after CFA injection [25] .
This increase is accompanied by an inward rectification of AMPA-induced currents and enhanced sensitivity to a highly selective Ca 2+ -permeable AMPAR blocker [25] . The Ca 2+ -permeability of AMPARs can also be visualized by kainate-induced cobalt uptake. One day after injecting one hind-paw of rats with CFA, we found that the number of cobalt-positive neurons was significantly increased in dorsal horn neurons on the side ipsilateral to the injection [25] .
Taken together, these findings suggest that peripheral inflammation leads to a switch from Ca 2+ -impermeable [19] ↓ ↑ − − − − IPl formalin [22] ↓∕↑ ↑ N/A N/A N/A N/A IPl carrageenan [21] by PKA elevates the channel open probability and peak amplitude of the AMPAR, increases GluA1 expression in the plasma membrane, and reduces AMPAR internalization [29] [30] [31] . Phosphorylation of GluA1 at Ser 831 by PKC/ CaMKII increases the signal channel conductance of synaptic AMPARs [32] . CaMKII activation also drives GluA1-containing AMPARs to synapses by a mechanism that requires the binding of GluA1 to its scaffolding protein [33] .
In addition, phosphorylation of GluA1 Ser 818 by PKC promotes GluA1 membrane insertion and facilitates an interaction with protein 4.1N, a scaffolding protein involved in the synaptic delivery and stabilization of GluA1 [34, 35] .
Further study showed that protein 4.1N is required for activity-dependent GluA1 insertion at extrasynaptic sites by PKC-dependent phosphorylation of GluA1 Ser 816 and Ser
818
. Phosphorylation at these sites enhances 4.1N binding to GluA1 and facilitates GluA1-containing AMPAR insertion into the extrasynaptic plasma membrane [36] . Thus, it is very likely that protein 4.1N and several serine phosphorylation sites of the GluA1 C-terminus participate in the regulation of synaptic and extrasynaptic GluA1 trafficking.
Peripheral inflammation alters the phosphorylation status of GluA1 serine residues. Intraplantar injection of capsaicin or CFA increases the phosphorylation of GluA1
Ser 831 and Ser 845 in the dorsal horn [37] [38] [39] . Our recent data demonstrated that dorsal horn PKCα knockdown blocks Recent evidence has revealed that spinal cord glial activation is involved in the increase of GluA1 phosphorylation and changes in GluA1 trafficking in the dorsal horn after inflammation. Choi et al. [21] showed that intraplantar carrageenan promoted GluA1 membrane insertion and phosphorylation of GluA1 Ser 845 in the dorsal horn but that these increases were blocked by a tumor necrosis factor (TNF) antagonist. Thus, the increased GluA1 phosphorylation and membrane insertion may be dependent on TNF, a proinflammatory cytokine. Additional investigation is needed to determine how TNF released from spinal glia participates in the regulation of neuronal GluA1 phosphorylation and trafficking in the dorsal horn after inflammation.
Like GluA1, GluA2 contains a binding motif at its
C-terminus for two scaffolding proteins: AMPAR-binding protein (ABP)/glutamate receptor-interacting protein (GRIP) and protein interacting with C kinase 1 (PICK1).
ABP/GRIP functions as an anchor to stabilize GluA2 at the synaptic membrane [40] [41] [42] . PICK1 acts as a transporter to recruit PKCα to ABP/GRIP-GluA2 complexes; the kinase then phosphorylates GluA2 at Ser 880 [43] [44] [45] . Studies from in vitro cell lines and neuronal culture have shown that GluA2 phosphorylation at Ser 880 by PKCα reduces the binding of GluA2 to ABP/GRIP, but not to PICK1, and promotes GluA2 internalization [43, 44, 46, 47] .
The data from our laboratory indicate that PKC phos- with both ABP/GRIP and PICK1, but PICK1 also binds to inactive PKCα in dorsal horn neurons [23] . In cultured dorsal horn neurons, activation of NMDA receptors and
PKCα markedly increases the level of GluA2 phosphorylation at Ser 880 and decreases the surface expression of GluA2 [23] . Activation of AMPARs and group 1 metabotropic glutamate receptors does not have this effect. Consistently, blockade of dorsal horn NMDA receptors and PKCα activity attenuates CFA-induced increases in GluA2 phosphorylation at Ser 880 and cytosolic GluA2 expression in the dorsal horn [23] (Fig. 1) . Furthermore, blocking the
CFA-induced increase in phosphorylation of GluA2 Ser 880
reduces CFA-evoked GluA2 internalization in dorsal horn neurons [23] . to GRIP1 is significantly reduced in dorsal horn neurons after intraplantar CFA injection [23] . Moreover, NMDA receptor-triggered GluA2 internalization requires Ca 2+ influx directly through the NMDA receptor channel [48, 49] . AMPA complexes are physically coupled to NMDA receptor complexes by a PSD-95-stargazin linkage with GluA1/2/4 and NR2A/NR2B and to PKCα by PICK1 with GluA2 in the dorsal horn [23] . This coupling may provide a molecular basis for an NMDA receptor-PKCα-AMPAR signal cascade and enable Ca 2+ to reach PKCα through NMDA receptor channel influx. The result would be phosphorylation of both GluA1 and GluA2 and changes in trafficking of both subunits. This conclusion is supported by the evidence that both GluA1 membrane insertion and GluA2 internalization require NMDA receptor activation in central neurons [23, [48] [49] [50] [51] [52] [53] . Therefore, NMDA receptor/PKCα activation may be responsible for CFA-induced changes of GluA1 and GluA2 trafficking in dorsal horn neurons after inflammation.
It should be noted that the binding motif in the GluA2 C-terminus also binds other proteins that are involved in the regulation of synaptic GluA2 trafficking. and facilitates the delivery or stabilization of GluA2 at the plasma membrane [54] [55] [56] . Interestingly, CFA-induced peripheral inflammation decreases NSF expression in the spinal cord [24] . Whether and how this decrease contributes to CFA-induced dorsal horn GluA2 internalization is unknown and needs additional study.
Changes in dorsal horn AMPAR subunit trafficking participate in central sensitization during inflammatory pain
The evidence presented so far indicates that peripheral inflammatory insults change AMPAR subunit trafficking and functional properties at synaptic and extrasynaptic sites of dorsal horn neurons. Lastly, I will review the literature to address whether these changes are involved in the development and maintenance of inflammation-induced pain hypersensitivity. It has been reported that the induction of dorsal horn GluA1 membrane insertion by capsaicin or carrageenan correlates with the development of pain hypersensitivity [19, 21] . Similarly, the GluA2 internalization and GluA1 membrane insertion that occur 1 to 3 days after peripheral CFA injection correlate with the maintenance of CFA-induced pain hypersensitivity [9, 23, 25] . Hence, inflammation-induced changes in dorsal horn AMPAR subunit trafficking are likely to participate in central sensitization during inflammatory pain. This conclusion is strongly supported by the following evidence. First, the activation of dorsal horn NMDA receptors and PKCα is required for inflammation-induced dorsal horn GluA2 internalization during the maintenance of inflammatory pain ( Fig.   1 ) [4, 23] ; second, our recent work showed that dorsal horn [23] [24] [25] 28] . Given that the NMDA receptor, Ca 2+ , and PKC are key players in inflammation-induced dorsal horn central sensitization [4, 57, 58] , I propose a model in which GluA1 membrane insertion and GluA2 internalization in the dorsal horn participate in the mechanism underlying the maintenance of central sensitization in inflammatory pain (Fig. 3) . In brief, after inflammation, NMDA receptor activation in- (Fig. 3 ).
Conclusion
Persistent (or chronic) pain is not simply the consequence of peripheral inputs or pathology but is also a reflection of changes in the plasticity of central nociceptive circuits (that is, central sensitization). These changes are sufficient to reduce the pain threshold, increase the magnitude and duration of responses to noxious input, and 
